Description
SUDEEP PHARMA LIMITED (Exchange ticker - 544619) will be added to the BSE IPO Index effective December 02, 2025, following its listing on BSE on November 28, 2025.
Summary
BSE has announced the addition of SUDEEP PHARMA LIMITED (Exchange ticker - 544619) to the BSE IPO Index. The stock is being listed on BSE on Friday, November 28, 2025, and will be added to the BSE IPO Index effective at the open of Tuesday, December 02, 2025. This action has been included in the end-of-day corporate action file.
Key Points
- SUDEEP PHARMA LIMITED (ticker: 544619) listed on BSE on November 28, 2025
- Stock will be added to BSE IPO Index effective December 02, 2025
- Addition will take effect at market open on December 02, 2025
- Corporate action included in end-of-day file (*.SDE)
- For queries, contact bseindex@bseindia.com
- References Notice No: 20251127-58
Regulatory Changes
No regulatory changes. This is a routine index composition update following a new stock listing.
Compliance Requirements
No specific compliance requirements for market participants. Index tracking funds and investors monitoring the BSE IPO Index should note the addition for portfolio rebalancing purposes.
Important Dates
- November 28, 2025: SUDEEP PHARMA LIMITED listing date on BSE
- December 02, 2025: Effective date for addition to BSE IPO Index (at market open)
Impact Assessment
Minimal market impact. This is a standard index maintenance action following a new IPO listing. The addition affects:
- Index funds tracking the BSE IPO Index may need to add the stock to their portfolios
- Passive investors and ETFs linked to the BSE IPO Index
- Index composition and weighting calculations
The BSE IPO Index tracks newly listed companies, so regular additions are expected as part of normal index operations.
Impact Justification
Routine index addition following new listing. Limited market impact as it affects only index composition and tracking funds.